Treatments for angiosarcoma can be intense, and it is important to monitor how your body responds. Common side effects include: Surgical Recovery: Pain, swelling and a limited range of motion in the ...

The Alliance AO91902 trial investigated whether adding immunotherapy to chemotherapy would improve outcomes for patients with advanced angiosarcoma. Although immunotherapy has become a mainstay of ...

Paclitaxel remains first-line for cutaneous angiosarcoma, but absence of validated second-line therapy creates a major unmet ...

“[...] PHA is a rare yet aggressive mesenchymal tumor of the liver, which requires a multi-disciplinary approach to achieve the best patient outcomes.” “In our ...

Angiosarcomas are aggressive soft-tissue sarcomas that are associated with high rates of local and distant recurrence and poor outcomes. [1,2] Close review of patient series and tumor characteristics ...

Angiosarcoma is an aggressive malignancy derived from endothelial cells, characterised by its rapid progression, heterogeneity and distinct clinical challenges. As a subset of soft tissue sarcomas, ...

Epidemiological trends and socioeconomic factors in malignant peripheral nerve sheath tumors with rhabdomyoblastic differentiation: A National Cancer Database study. This is an ASCO Meeting Abstract ...

Angiosarcoma of the gastrointestinal tract is an exceedingly rare and aggressive vascular tumour that arises from the endothelial cells lining blood vessels. Although primary angiosarcoma in this ...